DaVita logo
DVAI34 logo

DaVitaBOVESPA:DVAI34 Stock Report

Market Cap R$83.5b
Share Price
n/a
1Y80.4%
7D-4.7%
Portfolio Value
View

DVAI34 Stock Overview

Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. More details

DVAI34 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

DaVita Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for DaVita
Historical stock prices
Current Share PriceUS$998.07
52 Week HighUS$1,047.54
52 Week LowUS$604.00
Beta0.93
1 Month Change6.68%
3 Month Change15.59%
1 Year Change80.38%
3 Year Change58.97%
5 Year Change242.53%
Change since IPO398.21%

Recent News & Updates

Recent updates

Shareholder Returns

DVAI34BR HealthcareBR Market
7D-4.7%2.3%1.3%
1Y80.4%-21.3%-9.5%

Return vs Industry: DVAI34 exceeded the BR Healthcare industry which returned -21.3% over the past year.

Return vs Market: DVAI34 exceeded the BR Market which returned -9.5% over the past year.

Price Volatility

Is DVAI34's price volatile compared to industry and market?
DVAI34 volatility
DVAI34 Average Weekly Movement4.8%
Healthcare Industry Average Movement7.1%
Market Average Movement5.5%
10% most volatile stocks in BR Market9.6%
10% least volatile stocks in BR Market3.2%

Stable Share Price: DVAI34 has not had significant price volatility in the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine DVAI34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199470,000Javier Rodriguezwww.davita.com

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

DaVita Inc. Fundamentals Summary

How do DaVita's earnings and revenue compare to its market cap?
DVAI34 fundamental statistics
Market capR$83.55b
Earnings (TTM)R$4.77b
Revenue (TTM)R$72.97b

17.0x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DVAI34 income statement (TTM)
RevenueUS$12.67b
Cost of RevenueUS$8.51b
Gross ProfitUS$4.16b
Other ExpensesUS$3.33b
EarningsUS$827.68m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)10.09
Gross Margin32.80%
Net Profit Margin6.53%
Debt/Equity Ratio419.9%

How did DVAI34 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 03:24
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DaVita Inc. is covered by 37 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephan GasteygerAtlantic Equities LLP
Brian WilliamsAvondale Partners
Matthew GillmorBaird